Rekvina Laboratories Sees Major Stake Acquisition

Dhruvalkumar Patel has acquired 11,12,562 equity shares, or 10.01%, of Rekvina Laboratories Ltd.

Reader Takeaway: New 10.01% stakeholder enters; Shareholding pattern shifts significantly.

What just happened

Dhruvalkumar Patel has acquired a significant 10.01% stake in Rekvina Laboratories Ltd, amounting to 11,12,562 equity shares. This acquisition was executed through two primary methods: a preferential allotment of 2,22,562 shares on August 12, 2026, and an open offer for 8,90,000 shares on August 13, 2026. The filing is in line with SEBI's takeover regulations.

Why this matters

This substantial stake acquisition introduces a new major shareholder, potentially influencing the company's future strategic decisions and management outlook. For existing shareholders, monitoring the implications of this shift in ownership is crucial.

The backstory

The preferential allotment was a result of a Share Exchange and Purchase Agreement dated March 16, 2026. This transaction signifies a planned change in ownership structure.

What changes now

The company's equity capital has been impacted. Pre-acquisition, Rekvina Laboratories had Rs 3.01 crore in equity capital (60,28,000 shares). Post-acquisition, the equity capital has increased to Rs 5.56 crore (1,11,15,750 shares), reflecting the new shares issued and acquired.

Risks to watch

Potential changes in management or strategic direction are key risks for existing shareholders to monitor following this substantial acquisition.

Peer comparison

Information on peer stake acquisitions is not available in the provided filing.

Context metrics (time-bound)

• Total Shares Acquired: 11,12,562
• Percentage Stake Acquired: 10.01%
• Preferential Allotment Date: August 12, 2026
• Open Offer Date: August 13, 2026

What to track next

Investors should watch for any public statements or announcements from Rekvina Laboratories or Dhruvalkumar Patel regarding future plans or strategic shifts.